Studies provide new insights on mosquito-borne chikungunya virus infection

December 20, 2017, Wiley

The frequency of chronic joint pain after infection with chikungunya in a large Latin American cohort was 25% at a median of 20-months post-infection. In the Arthritis & Rheumatology study, significant predictors of persistent joint pain included being a college graduate, headache, knee pain, missed work, normal activities effected, four or more days of initial symptoms, and four or more weeks of initial joint pain.

The finding of chronic in one fourth of the patients infected with chikungunya, a mosquito-borne illness, approximately two years after initial infection has important implications for prediction of the magnitude of disability and health system costs after the Latin American epidemic.

The investigators hypothesized that persistent active chikungunya is responsible for chronic arthritis and joint and that chikungunya viral RNA would be present in the synovial fluid; however, in another study published in Arthritis & Rheumatology, the researchers did not detect viable virus after culture of synovial fluid in any of the participants who were studied for a median 22 months after infection.

Explore further: Tropical virus symptoms can mimic rheumatoid arthritis, study says

More information: Aileen Y. Chang et al, A cross-sectional analysis of chikungunya arthritis patients 22-months post-infection demonstrate no detectable viral persistence in synovial fluid, Arthritis & Rheumatology (2017). DOI: 10.1002/art.40383

Related Stories

Tropical virus symptoms can mimic rheumatoid arthritis, study says

February 21, 2015
(HealthDay)—The mosquito-borne chikungunya virus causes joint pain and swelling similar to rheumatoid arthritis, which can make diagnosis difficult, a new study says.

Drug combination effective against chikungunya arthritis in mice

February 1, 2017
Combining a drug for rheumatoid arthritis with one that targets the chikungunya virus can eliminate the signs of chikungunya arthritis in mice in the disease's earliest stage, according to researchers at Washington University ...

Chikungunya vaccine trial underway

June 6, 2017
The National Institutes of Health-funded Vaccine and Treatment Evaluation Unit at Baylor College of Medicine will be one of the sites for a clinical trial testing the safety and immune responses to a vaccine against chikungunya ...

Mosquito-borne chikungunya virus still a concern for American travelers, CDC says

November 6, 2014
(HealthDay)—Americans traveling to the Caribbean and Central and South America this winter need to be aware that an outbreak of the mosquito-borne disease chikungunya continues to spread in those areas, U.S. federal health ...

Confirmed cases of chikungunya soar in Brazil

November 24, 2016
Brazil's Health Ministry says that cases of chikungunya are soaring this year in Latin America's biggest country.

The signature of Chikungunya

August 31, 2015
Infection with the Chikungunya virus produces a 'signature' pattern of immune messenger molecules in the blood, according to the latest research from A*STAR scientists1. This discovery will hopefully improve patients' prognoses, ...

Recommended for you

Collaboration yields possible treatment for rare neurodegenerative disorder

October 23, 2018
St. Jude Children's Research Hospital investigators have developed a new class of compounds that extended the lives and eased symptoms of mice with a progressive neurodegenerative human disorder. The findings appear today ...

Genetic flaw causes problems for many with hypothyroidism

October 23, 2018
With an estimated 120 million prescriptions filled each year, the thyroid medicine levothyroxine (marketed as Synthroid ) is one of the most popular prescription medicines in the United States. Most patients who suffer from ...

'Game changer' tuberculosis drug cures 9 in 10

October 22, 2018
A new treatment for a drug-resistant strain of tuberculosis can cure more than 90 percent of sufferers, according to a trial hailed Monday as a "game changer" in the fight against the global killer.

Consuming caffeine from coffee reduces incident rosacea

October 22, 2018
(HealthDay)—Caffeine intake from coffee is inversely associated with the risk for incident rosacea, according to a study published online Oct. 17 in JAMA Dermatology.

AI doctor could boost chance of survival for sepsis patients

October 22, 2018
Scientists have created an artificial intelligence system that could help treat patients with sepsis.

Home-based biofeedback therapy is effective option for tough-to-treat constipation

October 22, 2018
Biofeedback therapy used at home is about 70 percent effective at helping patients learn how to coordinate and relax bowel muscles and relieve one of the most difficult-to-treat types of constipation, investigators report.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.